New diabetes drug ZT002 begins first human safety tests
NCT ID NCT05491421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested the safety and tolerability of a new drug called ZT002 in 32 healthy volunteers. Participants received either a single or multiple doses of ZT002 or a placebo by injection. The study aims to see if the drug is safe enough to move into larger trials for type 2 diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ZT002
What this could lead to
If successful, this could lead to a new injectable treatment for type 2 diabetes that helps control blood sugar.
What could go wrong
This is a very early Phase 1 trial with only 32 healthy participants, so it is not designed to prove effectiveness. The drug may cause side effects or fail in later trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Q-Pharm Pty Limited
Herston, Queensland, Australia